{"pmid":32344458,"title":"Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.","text":["Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications.","In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, China and spread globally, resulting in the first World Health Organization (WHO) classified pandemic in over a decade.(1) As of April 2020, the United States (US) has the most confirmed COVID-19 cases worldwide, but public health interventions and testing availability have varied across the country. (2).","Acad Emerg Med","Duanmu, Youyou","Brown, Ian P","Gibb, William R","Singh, Jessica","Matheson, Loretta W","Blomkalns, Andra L","Govindarajan, Prasanthi","32344458"],"abstract":["In December 2019, a novel coronavirus disease (COVID-19) emerged in Wuhan, China and spread globally, resulting in the first World Health Organization (WHO) classified pandemic in over a decade.(1) As of April 2020, the United States (US) has the most confirmed COVID-19 cases worldwide, but public health interventions and testing availability have varied across the country. (2)."],"journal":"Acad Emerg Med","authors":["Duanmu, Youyou","Brown, Ian P","Gibb, William R","Singh, Jessica","Matheson, Loretta W","Blomkalns, Andra L","Govindarajan, Prasanthi"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32344458","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/acem.14003","keywords":["covid-19","clinical characteristics","public health"],"locations":["Wuhan","China","United States","US"],"countries":["China","United States"],"countries_codes":["CHN|China","USA|United States"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1665351883837931520,"score":8.574329,"similar":[{"pmid":32093211,"pmcid":"PMC7074453","title":"Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.","text":["Characteristics of and Public Health Responses to the Coronavirus Disease 2019 Outbreak in China.","In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible.","J Clin Med","Deng, Sheng-Qun","Peng, Hong-Juan","32093211"],"abstract":["In December 2019, cases of unidentified pneumonia with a history of exposure in the Huanan Seafood Market were reported in Wuhan, Hubei Province. A novel coronavirus, SARS-CoV-2, was identified to be accountable for this disease. Human-to-human transmission is confirmed, and this disease (named COVID-19 by World Health Organization (WHO)) spread rapidly around the country and the world. As of 18 February 2020, the number of confirmed cases had reached 75,199 with 2009 fatalities. The COVID-19 resulted in a much lower case-fatality rate (about 2.67%) among the confirmed cases, compared with Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). Among the symptom composition of the 45 fatality cases collected from the released official reports, the top four are fever, cough, short of breath, and chest tightness/pain. The major comorbidities of the fatality cases include hypertension, diabetes, coronary heart disease, cerebral infarction, and chronic bronchitis. The source of the virus and the pathogenesis of this disease are still unconfirmed. No specific therapeutic drug has been found. The Chinese Government has initiated a level-1 public health response to prevent the spread of the disease. Meanwhile, it is also crucial to speed up the development of vaccines and drugs for treatment, which will enable us to defeat COVID-19 as soon as possible."],"journal":"J Clin Med","authors":["Deng, Sheng-Qun","Peng, Hong-Juan"],"date":"2020-02-26T11:00:00Z","year":2020,"_id":"32093211","week":"20209|Feb 24 - Mar 01","doi":"10.3390/jcm9020575","keywords":["2019-ncov","covid-19","sars-cov-2","clinical characteristics","coronavirus","diagnosis","pneumonia","prevention and control","public health","treatment"],"source":"PubMed","topics":["Treatment","Prevention","Mechanism","Diagnosis"],"weight":1,"locations":["Wuhan","Hubei","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664640875175608323,"score":182.08873},{"pmid":32279081,"title":"Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study.","text":["Clinical characteristics and outcomes of older patients with coronavirus disease 2019 (COVID-19) in Wuhan, China (2019): a single-centered, retrospective study.","BACKGROUND: In December 2019, the coronavirus disease 2019 (COVID-19) emerged in Wuhan city and spread rapidly throughout China and the world. In this study, we aimed to describe the clinical course and outcomes of older patients with COVID-19. METHODS: This is a retrospective investigation of hospitalized older patients with confirmed COVID-19 at Zhongnan Hospital of Wuhan University from January 1, 2020, to February 10, 2020. RESULTS: In total, 203 patients were diagnosed with COVID-19, with a median age of 54 years (interquartile range, 41-68; range, 20-91 years). Men accounted for 108 (53.2%) of the cases, and 55 patients (27.1%) were >65 years of age. Among patients who were 65 years and older, the mortality rate was 34.5% (19/55), which was significantly higher than that of younger patients at 4.7% (7/148). Common symptoms of older patients with COVID-19 included fever (94.5%; n=52), dry cough (69.1%; n=38), and chest distress (63.6%; n=35). Compared with young patients, older patients had more laboratory abnormalities and comorbidities. Through a multivariate analysis of the causes of death in older patients, we found that males, comorbidities, time from disease onset to hospitalization, abnormal kidney function, and elevated procalcitonin levels were all significantly associated with death. CONCLUSIONS: In the recent outbreak of COVID-19, our local hospital in Wuhan found that patients aged 65 and older had greater initial comorbidities, more severe symptoms, and were more likely to experience multi-organ involvement and death, as compared with younger patients.","J Gerontol A Biol Sci Med Sci","Chen, TieLong","Dai, Zhe","Mo, Pingzheng","Li, Xinyu","Ma, Zhiyong","Song, Shihui","Chen, Xiaoping","Luo, Mingqi","Liang, Ke","Gao, Shicheng","Zhang, Yongxi","Deng, Liping","Xiong, Yong","32279081"],"abstract":["BACKGROUND: In December 2019, the coronavirus disease 2019 (COVID-19) emerged in Wuhan city and spread rapidly throughout China and the world. In this study, we aimed to describe the clinical course and outcomes of older patients with COVID-19. METHODS: This is a retrospective investigation of hospitalized older patients with confirmed COVID-19 at Zhongnan Hospital of Wuhan University from January 1, 2020, to February 10, 2020. RESULTS: In total, 203 patients were diagnosed with COVID-19, with a median age of 54 years (interquartile range, 41-68; range, 20-91 years). Men accounted for 108 (53.2%) of the cases, and 55 patients (27.1%) were >65 years of age. Among patients who were 65 years and older, the mortality rate was 34.5% (19/55), which was significantly higher than that of younger patients at 4.7% (7/148). Common symptoms of older patients with COVID-19 included fever (94.5%; n=52), dry cough (69.1%; n=38), and chest distress (63.6%; n=35). Compared with young patients, older patients had more laboratory abnormalities and comorbidities. Through a multivariate analysis of the causes of death in older patients, we found that males, comorbidities, time from disease onset to hospitalization, abnormal kidney function, and elevated procalcitonin levels were all significantly associated with death. CONCLUSIONS: In the recent outbreak of COVID-19, our local hospital in Wuhan found that patients aged 65 and older had greater initial comorbidities, more severe symptoms, and were more likely to experience multi-organ involvement and death, as compared with younger patients."],"journal":"J Gerontol A Biol Sci Med Sci","authors":["Chen, TieLong","Dai, Zhe","Mo, Pingzheng","Li, Xinyu","Ma, Zhiyong","Song, Shihui","Chen, Xiaoping","Luo, Mingqi","Liang, Ke","Gao, Shicheng","Zhang, Yongxi","Deng, Liping","Xiong, Yong"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32279081","week":"202016|Apr 13 - Apr 19","doi":"10.1093/gerona/glaa089","keywords":["covid-19","sars-cov-2","wuhan","clinical characteristics","coronavirus","older patients"],"source":"PubMed","topics":["Diagnosis"],"weight":1,"locations":["Wuhan","China","Wuhan","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664636873203515393,"score":131.5337},{"pmid":32300496,"pmcid":"PMC7158591","title":"Coronavirus Disease: A Review of a New Threat to Public Health.","text":["Coronavirus Disease: A Review of a New Threat to Public Health.","In December 2019, several patients from Wuhan, China were admitted to hospitals with symptoms of pneumonia. As the number of patients presenting with similar symptoms started to rise, the causative agent was eventually isolated from samples. It was initially called the 2019 novel coronavirus (2019-nCoV) and has been recently relabelled as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); the disease it causes has been named coronavirus disease 2019 (COVID-19). Over the next few weeks, the virus spread from Wuhan to affect different provinces in China and, after a few months, it is now present in 109 countries. As of March 10, 2020, there have been 113,702 confirmed cases globally, and 4,012 deaths have been registered. The World Health Organization (WHO) called COVID-19 a pandemic on March 11, 2020. There are multiple drug trials going on with some positive results. However, since no vaccine is available, the best way to combat the virus is by preventive methods.","Cureus","Ramphul, Kamleshun","Mejias, Stephanie G","32300496"],"abstract":["In December 2019, several patients from Wuhan, China were admitted to hospitals with symptoms of pneumonia. As the number of patients presenting with similar symptoms started to rise, the causative agent was eventually isolated from samples. It was initially called the 2019 novel coronavirus (2019-nCoV) and has been recently relabelled as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); the disease it causes has been named coronavirus disease 2019 (COVID-19). Over the next few weeks, the virus spread from Wuhan to affect different provinces in China and, after a few months, it is now present in 109 countries. As of March 10, 2020, there have been 113,702 confirmed cases globally, and 4,012 deaths have been registered. The World Health Organization (WHO) called COVID-19 a pandemic on March 11, 2020. There are multiple drug trials going on with some positive results. However, since no vaccine is available, the best way to combat the virus is by preventive methods."],"journal":"Cureus","authors":["Ramphul, Kamleshun","Mejias, Stephanie G"],"date":"2020-04-18T11:00:00Z","year":2020,"_id":"32300496","week":"202016|Apr 13 - Apr 19","doi":"10.7759/cureus.7276","keywords":["coronavirus disease","covid-19","sars-cov-2","severe acute respiratory syndrome coronavirus 2","wuhan"],"source":"PubMed","topics":["Prevention","Diagnosis","Treatment"],"weight":1,"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664635401176875008,"score":128.75052},{"pmid":32219845,"title":"Responding to Covid-19: How to Navigate a Public Health Emergency Legally and Ethically.","text":["Responding to Covid-19: How to Navigate a Public Health Emergency Legally and Ethically.","Few novel or emerging infectious diseases have posed such vital ethical challenges so quickly and dramatically as the novel coronavirus SARS-CoV-2. The World Health Organization declared a public health emergency of international concern and recently classified Covid-19 as a worldwide pandemic. As of this writing, the epidemic has not yet peaked in the United States, but community transmission is widespread. President Trump declared a national emergency as fifty governors declared state emergencies. In the coming weeks, hospitals will become overrun, stretched to their capacities. When the health system becomes stretched beyond capacity, how can we ethically allocate scarce health goods and services? How can we ensure that marginalized populations can access the care they need? What ethical duties do we owe to vulnerable people separated from their families and communities? And how do we ethically and legally balance public health with civil liberties?","Hastings Cent Rep","Gostin, Lawrence O","Friedman, Eric A","Wetter, Sarah A","32219845"],"abstract":["Few novel or emerging infectious diseases have posed such vital ethical challenges so quickly and dramatically as the novel coronavirus SARS-CoV-2. The World Health Organization declared a public health emergency of international concern and recently classified Covid-19 as a worldwide pandemic. As of this writing, the epidemic has not yet peaked in the United States, but community transmission is widespread. President Trump declared a national emergency as fifty governors declared state emergencies. In the coming weeks, hospitals will become overrun, stretched to their capacities. When the health system becomes stretched beyond capacity, how can we ethically allocate scarce health goods and services? How can we ensure that marginalized populations can access the care they need? What ethical duties do we owe to vulnerable people separated from their families and communities? And how do we ethically and legally balance public health with civil liberties?"],"journal":"Hastings Cent Rep","authors":["Gostin, Lawrence O","Friedman, Eric A","Wetter, Sarah A"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32219845","week":"202013|Mar 23 - Mar 29","doi":"10.1002/hast.1090","keywords":["covid-19","allocation of scarce resources","civil liberties","crisis standards of care","novel coronavirus sars-cov-2","public health emergency","public health ethics"],"source":"PubMed","topics":["Prevention"],"weight":1,"locations":["United States"],"countries":["United States"],"countries_codes":["USA|United States"],"_version_":1664638742983344129,"score":126.696396},{"pmid":32204922,"pmcid":"PMC7102523","title":"COVID-19, a worldwide public health emergency.","text":["COVID-19, a worldwide public health emergency.","A new coronavirus outbreak emerged on the 31(st) of December 2019 in Wuhan, China, causing commotion among the medical community and the rest of the world. This new species of coronavirus has been termed 2019-nCoV and has caused a considerable number of cases of infection and deaths in China and, to a growing degree, beyond China, becoming a worldwide public health emergency. 2019-nCoV has high homology to other pathogenic coronaviruses, such as those originating from bat-related zoonosis (SARS-CoV), which caused approximately 646 deaths in China at the start of the decade. The mortality rate for 2019-nCoV is not as high (approximately 2-3%), but its rapid propagation has resulted in the activation of protocols to stop its spread. This pathogen has the potential to become a pandemic. It is therefore vital to follow the personal care recommendations issued by the World Health Organisation.","Rev Clin Esp","Palacios Cruz, M","Santos, E","Velazquez Cervantes, M A","Leon Juarez, M","32204922"],"abstract":["A new coronavirus outbreak emerged on the 31(st) of December 2019 in Wuhan, China, causing commotion among the medical community and the rest of the world. This new species of coronavirus has been termed 2019-nCoV and has caused a considerable number of cases of infection and deaths in China and, to a growing degree, beyond China, becoming a worldwide public health emergency. 2019-nCoV has high homology to other pathogenic coronaviruses, such as those originating from bat-related zoonosis (SARS-CoV), which caused approximately 646 deaths in China at the start of the decade. The mortality rate for 2019-nCoV is not as high (approximately 2-3%), but its rapid propagation has resulted in the activation of protocols to stop its spread. This pathogen has the potential to become a pandemic. It is therefore vital to follow the personal care recommendations issued by the World Health Organisation."],"journal":"Rev Clin Esp","authors":["Palacios Cruz, M","Santos, E","Velazquez Cervantes, M A","Leon Juarez, M"],"date":"2020-03-25T11:00:00Z","year":2020,"_id":"32204922","week":"202013|Mar 23 - Mar 29","doi":"10.1016/j.rce.2020.03.001","keywords":["Basic reproduction number","Clinical condition","Coronavirus","Cuadro clinico","Diagnosis","Diagnostico","Numero de reproduccion basico","Prevencion","Prevention","Transmision","Transmission"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352133681938432,"score":124.35014}]}